Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-20-133649
Filing Date
2020-12-09
Accepted
2020-12-09 16:15:29
Documents
1
Period of Report
2020-12-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2037947d1_6k.htm 6-K 10780
  Complete submission text file 0001104659-20-133649.txt   11979
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 201378001
SIC: 2834 Pharmaceutical Preparations